Focus on Cedric Francois, MD, PhD, CEO, Apellis Pharmaceuticals

Retina Synthesis

Mar 07, 2021•16 min•Ep. 16

--:--

Listen in podcast apps:

Apple Podcasts

Spotify

Download

Listen to this episode in Metacast mobile app

Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Dr. Francois discusses the epidemiology of geographic atrophy, the pathophysiology of complement inhibition in the treatment of GA, and the latest information on Apellis' Phase 2 and Phase 3 clinical trials.

For the best experience, listen in Metacast app for iOS or Android